Advertisement
Home Tags Parkinson’s

Tag: Parkinson’s

Outcomes Vary for Depression Collaborative Care Programs

Suicide Risk Higher Among Patients With Parkinson Disease

0

Increased risk not fully explained by higher rates of mental disorders

Exposure to air pollution is associated with an increased risk for neurological disorders in older adults

Air Pollution Tied to Neurological Disorders in Seniors

0
Higher fine particulate matter tied to higher risk for Parkinson disease, Alzheimer disease
COVID-19-related case fatality rates are higher for patients with Parkinson disease

COVID-19 Mortality Higher in Patients With Parkinson Disease

0
Higher case fatality rates found to be independent of demographic factors, such as age, sex, and race
Plasma caffeine concentration is lower in individuals with Parkinson disease

Plasma Caffeine Concentration Lower in Parkinson Disease

0
Results similar for caffeine metabolites and non-xanthine marker for coffee consumption in plasma
Increased adherence to alternate Mediterranean and Alternative Healthy Eating Index dietary patterns is inversely associated with prodromal features of Parkinson disease

Healthy Diet Inversely Linked to Prodromal Parkinson Disease Features

0
Adherence to aMED, AHEI dietary patterns inversely tied to constipation, daytime sleepiness, depression
Reduced circadian rhythmicity is associated with an increased risk for incident Parkinson disease

Reduced Circadian Rhythmicity Tied to Increase in Parkinson Disease

0
Risk for developing PD about threefold higher in lowest quartile of amplitude, mesor, robustness
More research is needed to determine the safety and efficacy of cannabis use for the treatment of Parkinson disease symptoms

Not Enough Evidence Exists to Support Cannabis for Parkinson Disease

0
Consensus statement calls for more rigorous research to assess clinical benefit
Telephone-based cognitive behavioral therapy seems to be an effective intervention for depression in Parkinson disease

Phone-Based Therapy Beneficial for Depression in Parkinson Disease

0
Telephone CBT outperformed treatment-as-usual on all depression, anxiety, quality-of-life measures
Thirty-six months of treatment with immediate-release isradipine does not slow clinical progression of early-stage Parkinson disease

Isradipine Does Not Slow Early Parkinson Disease Progression

0
Change in total Unified Parkinson's Disease Rating Scale score similar for isradipine versus placebo
Patients with Parkinson disease have a higher prevalence of ophthalmologic symptoms than controls

Ophthalmologic Symptoms Common in Parkinson Disease

0
Sixty-eight percent of patients have ophthalmologic symptoms that interfere with daily activities